CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities
Net loss	$ (4,717,489)	$ (2,073,082)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	76,916	10,650
Share-based compensation	487,524	696,843
Provision for bad debts and discounts	1,079,637	187,755
Provision for slow moving and obsolete inventory	2,704,612	711,828
Deferred taxes, net of valuation allowance	760,993	(533,639)
Changes in operating assets and liabilities:
Accounts receivable	(612,769)	2,598,303
Inventories	181,656	1,201,714
Prepaid expenses and other current assets	12,188	10,396
Accounts payable	(186,823)	(440,540)
Accrued expenses	125,458	568,280
Net cash (used in) provided by operating activities	(88,097)	2,938,508
Cash flows from investing activities
Purchase of property and equipment		(35,984)
Acquisition of Maxim Surgical, net of cash acquired		(63,097)
Net cash used in investing activities		(99,081)
Cash flows from financing activities
Payments on senior secured revolving credit facility, net	275,053	(2,651,799)
Net cash provided by (used in) financing activities	275,053	(3,049,262)
Net increase (decrease) in cash and cash equivalents	186,956	(209,835)
Cash and cash equivalents - beginning of period	844,314	804,715
Cash and cash equivalents - end of period	1,031,270	594,880
Supplemental disclosure of cash flow information:
Cash paid for interest	$ 69,257	84,872
Non-cash investing and financing activities:
Inventory contributed by stockholder		2,063,742
CPM [Member]
Cash flows from financing activities
Purchase price adjustment - CPM acquisition		(397,463)
Maxim Surgical, LLC [Member]
Non-cash investing and financing activities:
Stock issued for Maxim Acquisition		$ 3,200,000